FDA Approves Glycopyrrolate Oral Solution for Chronic Severe Drooling
The FDA has approved glycopyrrolate oral solution for the treatment of patients aged 3 to 16 years with chronic severe drooling associated with neurologic conditions, such as cerebral palsy.
Medscape Medical News
More Bad News for Rosiglitazone
Mounting evidence of adverse cardiovascular effects continues to erode justification for the use of rosiglitazone.
Journal Watch
High School Incompletion Rates Highest in Teens With ADHD
Teens with ADHD are more likely to drop out of high school or delay high school graduation than their counterparts with more "serious" mental health conditions, new national data suggest.
Medscape Medical News
Aggressive Glucose Control in Patients With Diabetes and Kidney Disease Not Associated With Improved Survival
A study suggests that in the absence of randomized controlled trials, aggressive management of HbA1c levels in patients with diabetes and end-stage kidney failure is not warranted.
Medscape Medical News
Daptomycin May Be Linked to Eosinophilic Pneumonia
In 7 cases reviewed by the FDA, patients developed eosinophilic pneumonia 2 to 4 weeks after starting daptomycin treatment.
Medscape Medical News